Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether long-term treatment with candesartan/hydrochlorothiazide, rosuvastatin, or their combination can slow cognitive decline in older people at intermediate cardiovascular risk. METHODS: The Heart Outcomes Prevention Evaluation-3 (HOPE-3) study was a double-blind, randomized, placebo-controlled clinical trial using a 2 × 2 factorial design. Participants without known cardiovascular disease or need for treatment were randomized to candesartan (16 mg) plus hydrochlorothiazide (12.5 mg) or placebo and to rosuvastatin (10 mg) or placebo. Participants who were ≥70 years of age completed the Digit Symbol Substitution Test (DSST), the modified Montreal Cognitive Assessment, and the Trail Making Test Part B at baseline and study end. RESULTS: Cognitive assessments were completed by 2,361 participants from 228 centers in 21 countries. Compared with placebo, candesartan/hydrochlorothiazide reduced systolic blood pressure by 6.0 mm Hg, and rosuvastatin reduced low-density lipoprotein cholesterol by 24.8 mg/dL. Participants were followed up for 5.7 years (median), and 1,626 completed both baseline and study-end assessments. Mean participant age was 74 years (SD ±3.5 years); 59% were women; 45% had hypertension; and 24% had ≥12 years of education. The mean difference in change in DSST scores was -0.91 (95% confidence interval [CI] -2.25 to 0.42) for candesartan/hydrochlorothiazide compared with placebo, -0.54 (95% CI -1.88 to 0.80) for rosuvastatin compared with placebo, and -1.43 (95% CI -3.37 to 0.50) for combination therapy vs double placebo. No significant differences were found for other measures. CONCLUSIONS: Long-term blood pressure lowering with candesartan plus hydrochlorothiazide, rosuvastatin, or their combination did not significantly affect cognitive decline in older people. CLINICALTRIALSGOV IDENTIFIER: NCT00468923. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for older people, candesartan plus hydrochlorothiazide, rosuvastatin, or their combination does not significantly affect cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Missing data analysis: making it work in the real world
Graham, J. W. (2009) · Annual Review of Psychology · doi:10.1146/annurev.psych.58.110405.085530 · Cited by 6,163
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Self-citationHachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898 · cited 1×
“Several trials that included participants at higher CVD risk or with higher baseline BPs suggested a benefit of BP lowering in preventing cognitive and functional decline, but even in this population, the results are inconsistent.(38,39) There was no effect of antihypertensive treatment on cognitive decline in those w…”
ResultCholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600176 · Cited by 848
Self-citationLauner, L. J., Miller, M. E., Williamson, J. D., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M., Horowitz, K. R., Ding, J., Marcovina, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70188-0 · Cited by 574
Gottesman, R. F., Schneider, A. L. C., Albert, M., Alonso, A., Bandeen-Roche, K., Coker, L., Coresh, J., Knopman, D., Power, M. C., Rawlings, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1646 · Cited by 474 · cited 3×
“It is possible that a treatment duration of 5.7 years may not be long enough to prevent cognitive decline, especially in a population with normal BP.11 The slower rate of decline seen in the group with higher baseline BP and lipids and the potential benefit of longer treatment should be evaluated in future studies.”
BackgroundInfluentialMcGuinness, B., Todd, S., Passmore, P., & Bullock, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004034.pub3 · Cited by 315 · cited 1×
“While a relationship between BP and cognition seems evident, BP-lowering studies do not consistently demonstrate less cognitive decline.(34,35) These studies included low-risk participants, were of short duration, and used insensitive tools (such as Mini-Mental State Examination) to measure change in cognition.”
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis
Levi Marpillat, N., Macquin-Mavier, I., Tropeano, A.-I., Bachoud-Levi, A.-C., & Maison, P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283603f53 · Cited by 254
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Hughes, D., Judge, C., Murphy, R., Loughlin, E., Costello, M., Whiteley, W., Bosch, J., O’Donnell, M. J., & Canavan, M. (2020) · JAMA · doi:10.1001/jama.2020.4249 · Cited by 472
Self-citationGovindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab208 · Cited by 197
Midlife lipid and glucose levels are associated with Alzheimer's disease
Zhang, X., Tong, T., Chang, A., Ang, T. F. A., Tao, Q., Auerbach, S., Devine, S., Qiu, W. Q., Mez, J., Massaro, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12641 · Cited by 65
Metadata
- Authors
- Bosch, J., O'Donnell, M., Swaminathan, B., Lonn, E. M., Sharma, M., Dagenais, G., Diaz, R., Khunti, K., Lewis, B. S., Avezum, A., Held, C., Keltai, M., Reid, C., Toff, W. D., Dans, A., Leiter, L. A., Sliwa, K., Lee, S. F., Pogue, J. M., Hart, R., Yusuf, S., on behalf of the HOPE-3 Investigators, on behalf of the HOPE-3 Investigators, Alzogaray, M., Aparici, M., Berli, M., Bevacqua, M., Labarta, M. B., Bustos, B., Caccavo, A., Candiello, A., Carignano, M., Carrillo, N., Carro, N., Cartasegna, L., Casali, W., Cassettari, A., Centeno, M., Cuello, J., Cuneo, C., Cusimano, S., Damonte, C., De Landaluc, M., De Martino, E., Diez, R., Fernandez, A., Ferrari, A., Forti, L., Galello, M., Garcia, C., Duran, R. G., Garrido, M., Giachello, F., Vilamajo, O. G., Gonzalez, M., Guerlloy, F., Guerrero, R., Hominal, M., Hrabar, A., Imposti, H., Lanchiotti, P., Laugle, C., Liniado, G., Litvak, M. R., Longhi, A., Luciardi, H., Mackinnon, I., Manzano, R., Marino, J., Merlo, B., Milesi, R., Mulazzi, C., Nemi, S., Orio, S., Pelagagge, M., Raimondi, S., Rodino, L., Rodriguez, C., Sago, L., Sala, J., Sanchez, A., Sanchez, R., Santos, D., Schygiel, P., Sernia, V., Smith, T., Sokn, F., Soso, L., Trivi, M., Vico, M., Villamil, A., Vogel, D., Zaidman, C., Abhayaratna, W., Canalese, J., Krum, H., Patel, A., Brasil, C. K. O. L., Alves, C. B., Alves, A. R., Ayoub, J. C. A., Bergoli, L. C. C., Blacher, M. G., Bodanese, L. C., Braga, J. C. F., Costa, O. M. C., Costa, M. K. M., de Faria, D. G., Del Monaco, M. I., Restelatto, L. F., Filho, F., Franco, R. J. S., Furtado, M. V., Leaes, P. E., Leaes, P., Maia, L. N., MarinNeto, J. A., Mattar, E. T. B., Melo, C. M., Mothe, F. S., Oliveira, G. B. F., Pelloso, E., Polanczyk, C. A., Rosa, P. R., Sales, S. O. C., Saraiva, J. F. K., Schmidt, A., Silva, V. S., Sousa, A. C. S., Valle, A. P., Wiehe, M., Abramson, B., Anand, S., Aw, J., Baxter, W., Berlingieri, J., Cha, J., Chaulk, R., Chetty, T., Dagenais, G., Dattani, D., Delage, F., Dion, D., Dominguez, M., Gallo, R., Glendinning, K., Goldman, H., Gosselin, G., Greenspoon, A., Ly, Q. H., Juneau, M., Keegan, P., Kelly, A., Kilby, D., Lavoi, M., Leiter, L. A., Lonn, E., Magloire, P., Mehta, P., Mercante, N., Miscescu, H., Moran, G., Nawaz, S., Nigam, A., Pang, P., Papp, E., Petrella, R., Poirier, C., Rabasa-Lhoret, R., Rizvi, Q., Saulnier, D., Sharma, M., Sohal, P., Stern, S., Tobe, S., Walsh, P., Ward, R., Weeks, A., Woo, V., Yellin, J., Zuliani, P., Bai, X. J., Dong, L. G., Duan, Y. W., Feng, J. Z., Fu, P., Gao, M. M., Gao, P., Ge, H., Ge, Y., Hua, Q., Li, D. J., Liu, X. L., Liu, X. L., Liu, Z. D., Liu, Y. J., Liu, F. Y., Liu, L. H., Lu, F. H., Lv, T., Ma, S. P., Ma, H., Man, R. H., Tan, H. Q., Shen, Y., Shi, J. F., Sun, X. D., Wang, S. Y., Wang, B., Wang, Y. Q., Wei, Y. J., Yang, X. C., Yang, H. S., Yu, K., Yu, L. T., Yu, J. H., Zhang, W., Zhang, W., Zhang, F., Zhang, H. Y., Zhang, B., Zhao, J. G., Zhao, Y., Accini, J., Arcos, E., Aroca, G., Casanova, M., Celemin, C., Coronel, B. J., Cotes, C., Cure, C., Diego-Olite, M., Duarte, A., Escobar, D., Figueredo, M., Garcia, L., Garcia, H., Grisales, M., Martinez, K., Molina de Salazar, D. I., Castellanos, B. N., Posada, I., Quintero, A., Quiros, F., Sanchez, G., Sotomayor, A., Suarez, M., Urina, M., Adamkova, V., Cifkova, R., Ferkl, R., Galovcova, M., Hartman, J., Jozifova, M., Linhart, K., Linhart, T., Moravcikova, D., Nussbaumerova, B., Plachy, M., Rosolova, H., Seifert, B., Soucek, M., Duarte Vera, Y., Espinel, M., Lopez-Jaramillo, M., McDermont, J., Penaherrera, E., Plascencia, F., Pow-Chon-Long, F., Tettamanti, D., Bajnok, L., Baranyi, E., Bartfai, E., Bod, E., Bodis, B., Czuriga, I., Huber, E., Mezosi, E., Poor, F., Somos, E., Tarjanyi, Z., Tatrai, T., Tomcsanyi, J., Vertes, A., Zsary, A., Aggarwal, D. K., Alexander, K. G., Aman, S. D., Ayyar, V., Balaji, Y., Bantwal, G., Bosco, B., Chidambaram, N., Dabra, A., Daniel, S., Deshpande, N., Devendra, H. R., Ghoshroy, D., Gnanasekaran, S., Gupta, R., Gutti, M. Z., Joshi, G. S., Joshi, S., Kalantri, S. P., Kapoor, A., Khan, A., Khedar, R. S., Manjunath, A. R., Mehta, K., Mohan, V., Murthy, S., Nambiar, A., Narendra, J., Paul, S. K., Qureshi, M. A., Rajasekaran, S., Ramu, M., Rangadham, K., Ranka, R. L., Roy, S., Sathyanarayan, M. R., Selvam, K., Sethuraman, J. P., Shunmugvavelu, M., Sidhu, G., Singh, B., Singh, R., Sinha, N., Srinivas, J., Srinivas, A., Srinivasulu, B., Thomas, N., Umarani, R., Varghese, K., Varma, S., Yelvatkar, S., Biton, A., Goldhaber, A., Ivri, S., Shapiro, I., Shveydel, N., Shveydel, E., Tsalihin, D., Vinker, S., Yosefy, C., Choe, K. H., Kil Kim, S., Ambigga, D., Aris, M. A., Ghapar, K. A., Krishnan, C., Mahadasa, P., Maizatullifah, M., Mazapuspavina, Y., Ramanathan, L., Mohd Shah, A. S., Yusoff, K., Bonarius, J. H., De Jong, A., DeRuiter, Z., DeVos, R., Dirkse, H. A., Drenth, E., Ferguson, H., Jansen, R., Mevissen, H., Rol, H., Schilder, A., Spelt, I., VanLeeuwen, P., Abola, M., Co, H., Loyola, A., Mercado, J., Morales, D., Padua, L., Palileo, L., Patanao, A., Rogelio, G., Roxas, A., Sulit, D., Tang-Manga, A., Tumanan-Mendoza, B., Boytsov, S., Chukaeva, I., Karpov, Y., Kisliak, O., Kobalava, Z., Ledyacva, A., Lopatin, Y., Nedogoda, S., Solovieva, M., Tsoma, V., Tyurina, T., Hranai, M., Badat, A., Sliwa, K., Gerntholtz, T., Al-Khalili, F., Carlberg, B., Dotevall, A., Nilsson, P., Olsson, A., Rosengren, A., Soderberg, S., Artomov, D., Babanina, T., Bagriy, A., Danyliuk, S., Doretska, N., Dorovska, O., Dovgan, N., Dzyak, G., Glushko, L., Gorbas, I., Ilashchuk, T., Karapetyan, K., Karavanska, I., Khimion, L., Khorsun, A., Kononenko, L., Kuryata, O., Kvasha, O., Lazareva, S., Loktyev, D., Lysenko, G., Miroshnchenko, N., Onyschenko, O., Parkhomenko, A., Petryk, N., Pivovarova, S., Rakytskay, I., Sapozhnychenko, L., Smymova, I., Soya, O., Tashchuk, V., Turubarova-Leunova, N., Vasilyeva, L., Velichko, N., Yagensky, A., ZhurbaK. Khunti, S., Loke, I., & Toff, W. D.
- Venue
- Neurology
- Published
- 2019-03-26
- Volume
- 92
- Issue
- 13
- Pages
- e1435-e1446
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2915579921
- Cited by
- 85
- References
- 14
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study. https://app.cochat.ai/papers/10.1212/wnl.0000000000007174
- The paper
- Bosch, J., O'Donnell, M., Swaminathan, B., Lonn, E. M., Sharma, M., Dagenais, G., Diaz, R., Khunti, K., Lewis, B. S., Avezum, A., Held, C., Keltai, M., Reid, C., Toff, W. D., Dans, A., Leiter, L. A., Sliwa, K., Lee, S. F., Pogue, J. M., . . . Toff, W. D. (2019). Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study. Neurology. https://doi.org/10.1212/wnl.0000000000007174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.